uniQure N.V. Share Price

uniQure N.V. Share Price

NASDAQ: QURE | Small Cap
$20.75
-$1.09 (-4.97%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

uniQure N.V. Stock Performance

Open
$21.76
Prev. Close
$21.84
Circuit Range
N/A
Day Range
$20.60 - $21.76
Year Range
$8.74 - $51.63
Volume
80,809
Average Traded
$20.91

uniQure N.V. Share Price Today

As of 18 November 2026, uniQure N.V.'s share price is $20.75. The stock opened at $21.76, compared to its previous close of $21.84. During today's trading session, uniQure N.V.'s share price traded between $20.60 and $21.76, with an average price of $21.18. Over the past 52 weeks, the stock has recorded a high of $51.63 and a low of $8.74. In terms of performance, uniQure N.V.'s share price has declined by 27.22% over the last six months and is down 24.46% on a year-on-year basis.

uniQure N.V. Share Price Chart

Line chart of the uniQure N.V. price trend over the selected period. The price fell overall, ranging from 20.60 to 21.74, ending at 20.76.
$20.60$21.76
L
Show Current Price
H

uniQure N.V. Stock Fundamentals & Key Indicators

Market Cap
$1.19B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.32
Revenue (TTM)
$16.10B
Return On Equity (TTM)
-79.04%
Profit Margin
-1235.84%
Debt to Equity
0.17
Quarterly Earnings Growth YoY
-65.06%

uniQure N.V. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$5.57$3.56$5.84$5.20
Net Profit-$37.09-$53.54-$81.06-$61.22
Net Profit Margin-665.89%-1503.93%-1388.01%-1177.31%
Income ChangeN/A-44.35%-51.40%24.48%

uniQure N.V. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$106.48$15.84$27.12$16.10
Net Profit-$126.79-$308.48-$239.56-$198.97
Net Profit Margin-119.07%-1947.47%-883.33%-1235.84%
Income ChangeN/A-143.30%22.34%16.94%

About uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

uniQure N.V. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$26.18
$20.74
-16.42%
Oct 2026
$24.16
$24.82
+3.10%
Sep 2026
$48.70
$24.07
-51.40%
Aug 2026
$43.19
$49.53
+13.47%
Jul 2026
$46.15
$43.65
-5.16%
Jun 2026
$27.66
$46.02
+61.43%
May 2026
$19.84
$28.51
+42.94%
Apr 2026
$17.53
$19.95
+22.06%
Mar 2026
$9.22
$16.34
+4.91%
Feb 2026
$22.67
$15.57
-31.45%
Jan 2026
$23.91
$22.72
-4.90%
Dec 2025
$26.64
$23.89
-13.03%

QURE Share Price FAQs